Compare ACHV & INVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACHV | INVZ |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | Israel |
| Employees | N/A | 415 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.0M | 144.1M |
| IPO Year | 2018 | N/A |
| Metric | ACHV | INVZ |
|---|---|---|
| Price | $4.56 | $0.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $14.67 | $2.68 |
| AVG Volume (30 Days) | 1.6M | ★ 2.1M |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $29.61 |
| Revenue Next Year | N/A | $53.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.00 | $0.58 |
| 52 Week High | $6.03 | $2.54 |
| Indicator | ACHV | INVZ |
|---|---|---|
| Relative Strength Index (RSI) | 60.45 | 47.93 |
| Support Level | $4.04 | $0.61 |
| Resistance Level | $5.13 | $0.74 |
| Average True Range (ATR) | 0.42 | 0.05 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 44.16 | 45.68 |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.